All 15 departments of radiotherapy completed the questionnaire. Regarding the type of department, there were 46.7% private hospital/clinic, 33.3% Institute of Oncology, and 20% in the county/city public hospital. Most of the clinics have been equipped since 2015. As equipment, there were: 11 Varian (Gammamed IX, Ir192) and 4 Elekta (2 Flexiton Ir192, 2 Selectron Ir192). 60% of treatments were provided by insurance company, 26.7% by private payment, and 13.3% by both. 3656 p were treated with BT and 10634 procedures were done in 2021. Endocavitary BT was available in all departments, interstitial for 40%, contact for 40%, and intraluminal for 13.3%. For the treatment plan imaging, 86.7% were made on CT, 26.7% on X-rays, 13.3% on MRI, and 6.7% on endorectal US. All the departments temporary implant was used. The types of cancer treated with BT were: 100% gynecological cancers, 40% rectal/anal cancer, 33.3% skin cancers, 20% sarcomas, and esophageal cancers, 13.3% prostate and breast cancer, 6.7% ENT and lung cancers. The most important n of p treated by type of cancer per 2021 were: gynecological (1198), skin (53 p), prostate (21), sarcomas (7), rectal (3), and breast (1). The main problems reported by the departments were underfunding of BT services, staff training, and implementation of interstitial BT in the public system. All the departments consider that BT training courses should be organized regularly in our country.